Aktie MLM MOLMED S.P.A.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen MolMed S.p.A.

Aktien

MLM

IT0001080248

MLM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Genenta Science S.p.A. and AGC Biologics S.p.A. Enter into A Development and Manufacturing Services Agreement
AGC Biologics and W.L. Gore & Associates Collaborate on New Protein A-Based Purification Technology and Contract Manufacturing Services for Antibody Therapies
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
AGC Biologics Partners with BioNTech SE to Further Supply Plasmid DNA Starting Material for the Pfizer-BioNTech COVID-19 vaccine, at AGC’s Heidelberg, Germany facility
MolMed Announces Transition of Luca Alberici from the Role of Chief Business Officer
MolMed S p A : Delisting
MolMed S p A : CS_ integrativo del Comunicato dimissioni consiglieri
MolMed S.p.A.(BIT:MLM) dropped from S&P Global BMI Index
AGC Inc. completed the acquisition of 93.2% in MolMed S.p.A. from Finanziaria d'investimento Fininvest S.p.A. and others for approximately €220 million.
Atlantia : Borsa Milano parte positiva, Atlantia cede oltre 12% su timori revoca
Atlantia : Borsa Milano in rialzo con Stm, auto e banche, deboli lusso e energia
Atlantia : Borsa Milano in rialzo spinta da buoni dati produzione industriale
Atlantia : Borsa Milano poco mossa in avvio, brillano Atlantia, Molmed
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
AGC : Italy to use vetting powers in Molmed acquisition by Japan's AGC
University of Tartu: Novel DNA analysis will help to identify food origin and counterfeit food in the future
Karolinska Institutet: Overlooked protein could play important part in pneumonia and COVID-19, researchers say
University of Bristol: UK genome analysis has important implications for COVID-19 clinical trials
AGC Inc. entered into an agreement to acquire MolMed S.p.A. from Finanziaria d'investimento Fininvest S.p.A. and others for approximately €240 million.
MolMed S p A : KU awards 38 PhD, 16 M. Phil, two Master of Surgery degrees
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. MLM Aktie
  4. Nachrichten MolMed S.p.A.
  5. Andere Sprachen